1. Home
  2. UHAL vs RDY Comparison

UHAL vs RDY Comparison

Compare UHAL & RDY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo U-Haul Holding Company

UHAL

U-Haul Holding Company

HOLD

Current Price

$52.77

Market Cap

10.0B

ML Signal

HOLD

Logo Dr. Reddy's Laboratories Ltd

RDY

Dr. Reddy's Laboratories Ltd

HOLD

Current Price

$14.19

Market Cap

11.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UHAL
RDY
Founded
1945
1984
Country
United States
India
Employees
35100
N/A
Industry
Rental/Leasing Companies
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.0B
11.6B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
UHAL
RDY
Price
$52.77
$14.19
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$16.90
AVG Volume (30 Days)
193.4K
938.9K
Earning Date
11-05-2025
01-22-2026
Dividend Yield
N/A
0.50%
EPS Growth
N/A
9.95
EPS
1.19
0.79
Revenue
$5,972,459,000.00
$3,851,623,984.00
Revenue This Year
$6.61
$6.16
Revenue Next Year
$4.20
$2.57
P/E Ratio
$44.19
$17.87
Revenue Growth
5.86
14.10
52 Week Low
$48.48
$12.26
52 Week High
$75.19
$16.17

Technical Indicators

Market Signals
Indicator
UHAL
RDY
Relative Strength Index (RSI) 49.51 57.67
Support Level $48.48 $13.64
Resistance Level $54.39 $14.20
Average True Range (ATR) 1.26 0.16
MACD 0.42 0.05
Stochastic Oscillator 68.10 98.25

Price Performance

Historical Comparison
UHAL
RDY

About UHAL U-Haul Holding Company

U-Haul Holding Co is an American moving truck, trailer, and self-storage rental company. The company also provides moving boxes, packing supplies, LPG (propane) refills, trailer hitch and wiring installation, storage container rentals, and other services. It has three reportable segments Moving and Storage, Property and Casualty Insurance, and Life Insurance. The majority of its revenue comes from the Moving and Storage segment.

About RDY Dr. Reddy's Laboratories Ltd

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

Share on Social Networks: